JANX011
ARMV-011-001
Phase 1 small_molecule active
Quick answer
JANX011 for Autoimmune is a Phase 1 program (small_molecule) at Janux Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Janux Therapeutics
- Indication
- Autoimmune
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active